JAMA analysis stirs debate

A JAMA analysis questioning the effectiveness of antidepressants has renewed debate.

The meta-analysis found that antidepressents are useful for those with severe depression symptoms but don't work any better than placebo in mild cases. In a letter to The New York Times, Weill Cornell psychiatry professor Dr. Richard Friedman derided the research for including only two drugs and for excluding studies that screened out placebo responders.

Two of the researchers defended their methodology, saying many approved antidepressants vary little in effectiveness and that their aim was to estimate effects of medications vs. placebos.

You must be a registered member of MMM to post a comment.

Next Article in Features

Content marketing is not advertising in the old sense. In its use of social media, content marketing challenges consumers while relying on their input. It is proactive and responsive to their concerns, needs and energy. Content marketing has become the new voice of marketing. Learn what you need to know and how pharma marketers can adapt to this innovative venture into social media by clicking here for access.

Email Newsletters